Argus
•
Sep 02, 2026
McKesson Corporation: Raising target price
Summary
McKesson, which is headquartered in Irving, Texas, operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical (until spun-off).
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Technical Assessment: Bullish in the Intermediate-Term
Sep 03, 2026
•
HUM, FCX
Analyst Report: Cencora, Inc.
Sep 02, 2026
•
COR
CI: Raising target price to $311.00
Sep 02, 2026
•
CI
DVA: Lowering target price to $185.00
Sep 02, 2026
•
DVA
HSIC: Lowering target price to $93.00
Sep 02, 2026
•
HSIC
Analyst Profile
David H. Toung
Senior Analyst: Medical Devices & Healthcare Services
David covers the Pharmaceutical, Medical Devices, and Healthcare services sectors for Argus. He has more than two decades of experience in the financial analysis industry, having worked for McDonald & Co., JPMorgan Chase and Standard & Poor's, among others. His commentary has appeared on CNBC and in The New York Times. Prior to his financial career, David was a private practice attorney in New Jersey, and served as a Judicial Clerk for an Appellate Division judge in the New Jersey Superior Court. David has a law degree from Rutgers University, where he was a member of the Law Review. He has a B.A. degree in Government from Cornell University. He has passed Level II of the Chartered Financial Analyst examination.
